Project team members please navigate to the ASSERT files page and log in to gain access to project files.
Welcome UCSF, UC Davis, and UT Southwestern collaborators!
The ASSERT trial is a study of how oncologists communicate the risks and benefits of treatment options to node-negative, Her2-negative breast cancer patients. Specifically the study will examine how this subset of patients respond to oncologists' presentations of evidence regarding adjuvant therapy effectiveness during oncology visits. Oncologists at the University of California, San Francisco (UCSF), University of California Davis (UCD), and the University of Texas Southwestern (UT/SW) will be randomized into two groups, an Intervention Group who will use a packaged teaching tool to summarize treatment risks and benefits, and a Control Group that will engage in usual care. Therefore, patients will receive from their oncologists either the oncologist's standard presentation, or the usual presentation plus a structured sequence of visual aids presented and interpreted by the oncologist during the consultation (the Adjuvant Survival, Side Effects, and Recurrence Tool, ASSERT).
To explore a demo of the ASSERT tool, click here. Because this is a demo version, there is no real patient data stored. Therefore, when prompted for a login, click the "Submit" button to enter.